Actuate Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Actuate Therapeutics, Inc. (ACTU) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.97 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.06M shares, a 77.16% increase year-over-year.
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.73M shares, a 88.49% decline year-over-year.
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 14.99M shares.
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.13M shares, a 92.22% increase from fiscal 2024.
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.63M shares, a 88.64% decline from fiscal 2023.
- Actuate Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.32M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.97M shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 3.06M shares 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 3.13M shares 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 3.09M shares 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 3.30M shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 1.73M shares 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 1.63M shares 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 1.64M shares 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 15.10M shares 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | 14.99M shares 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | 14.32M shares 10-K · filed 2025-03-13 | |||
| 2023-09-30 | 14.31M shares 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | 14.12M shares 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |